BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 8683987)

  • 41. Genomic structure, expression and mutational analysis of the P15 (MTS2) gene.
    Stone S; Dayananth P; Jiang P; Weaver-Feldhaus JM; Tavtigian SV; Cannon-Albright L; Kamb A
    Oncogene; 1995 Sep; 11(5):987-91. PubMed ID: 7675459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Homozygous deletions of p16/MTS1 gene are frequent but mutations are infrequent in childhood T-cell acute lymphoblastic leukemia.
    Ohnishi H; Kawamura M; Ida K; Sheng XM; Hanada R; Nobori T; Yamamori S; Hayashi Y
    Blood; 1995 Aug; 86(4):1269-75. PubMed ID: 7632931
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frequent loss of heterozygosity on chromosome 9, and low incidence of mutations of cyclin-dependent kinase inhibitors p15 (MTS2) and p16 (MTS1) genes in gliomas.
    Li YJ; Hoang-Xuan K; Delattre JY; Poisson M; Thomas G; Hamelin R
    Oncogene; 1995 Aug; 11(3):597-600. PubMed ID: 7630644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia.
    Cayuela JM; Madani A; Sanhes L; Stern MH; Sigaux F
    Blood; 1996 Mar; 87(6):2180-6. PubMed ID: 8630377
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Infrequent mutations and no methylation of CDKN2A (P16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan.
    Lin YW; Chen CH; Huang GT; Lee PH; Wang JT; Chen DS; Lu FJ; Sheu JC
    Eur J Cancer; 1998 Oct; 34(11):1789-95. PubMed ID: 9893670
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Infrequent somatic mutations of the p16 and p15 genes in human bladder cancer: p16 mutations occur only in low-grade and superficial bladder cancers.
    Miyamoto H; Kubota Y; Fujinami K; Dobashi Y; Kondo K; Yao M; Shuin T; Hosaka M
    Oncol Res; 1995; 7(7-8):327-30. PubMed ID: 8747595
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias.
    Hayette S; Thomas X; Bertrand Y; Tigaud I; Callanan M; Thiebaut A; Charrin C; Archimbaud E; Magaud JP; Rimokh R
    Leukemia; 1997 Oct; 11(10):1696-9. PubMed ID: 9324291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study.
    Kim M; Yim SH; Cho NS; Kang SH; Ko DH; Oh B; Kim TY; Min HJ; She CJ; Kang HJ; Shin HY; Ahn HS; Yoon SS; Kim BK; Shin HR; Han KS; Cho HI; Lee DS
    Cancer Genet Cytogenet; 2009 Nov; 195(1):59-65. PubMed ID: 19837270
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies.
    Ogawa S; Hangaishi A; Miyawaki S; Hirosawa S; Miura Y; Takeyama K; Kamada N; Ohtake S; Uike N; Shimazaki C
    Blood; 1995 Aug; 86(4):1548-56. PubMed ID: 7632963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias.
    Hebert J; Cayuela JM; Berkeley J; Sigaux F
    Blood; 1994 Dec; 84(12):4038-44. PubMed ID: 7994022
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Homozygous deletions but no sequence mutations in coding regions of p15 or p16 in human primary bladder tumors.
    Packenham JP; Taylor JA; Anna CH; White CM; Devereux TR
    Mol Carcinog; 1995 Nov; 14(3):147-51. PubMed ID: 7576106
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular analysis of a family of cyclin-dependent kinase inhibitor genes (p15/MTS2/INK4b and p18/INK4c) in non-small cell lung cancers.
    Kawamata N; Miller CW; Koeffler HP
    Mol Carcinog; 1995 Dec; 14(4):263-8. PubMed ID: 8519415
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutational and expression analysis of the chromosome 12p candidate tumor suppressor genes in pre-B acute lymphoblastic leukemia.
    Montpetit A; Larose J; Boily G; Langlois S; Trudel N; Sinnett D
    Leukemia; 2004 Sep; 18(9):1499-504. PubMed ID: 15284860
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Homozygous deletions at 9p21 in childhood acute lymphoblastic leukemia detected by microsatellite analysis.
    Takeuchi S; Koike M; Seriu T; Bartram CR; Slater J; Park S; Miyoshi I; Koeffler HP
    Leukemia; 1997 Oct; 11(10):1636-40. PubMed ID: 9324282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell lines.
    Siebert R; Willers CP; Schramm A; Fosså A; Dresen IM; Uppenkamp M; Nowrousian MR; Seeber S; Opalka B
    Br J Haematol; 1995 Oct; 91(2):350-4. PubMed ID: 8547074
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deletion of the Ink4-locus (the p16ink4a, p14ARF and p15ink4b genes) predicts relapse in children with ALL treated according to the Nordic protocols NOPHO-86 and NOPHO-92.
    Calero Moreno TM; Gustafsson G; Garwicz S; Grandér D; Jonmundsson GK; Frost BM; Mäkipernaa A; Rasool O; Savolainen ER; Schmiegelow K; Söderhäll S; Vettenranta K; Wesenberg F; Einhorn S; Heyman M
    Leukemia; 2002 Oct; 16(10):2037-45. PubMed ID: 12357355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inactivation of the p15 gene in children with acute lymphoblastic leukemia.
    Cipolotti R; Lemos JA; Defavery R; Scrideli CA; Dal Fabbro AL; Tone LG
    Sao Paulo Med J; 2003 Sep; 121(5):203-6. PubMed ID: 14666292
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alterations of p16 and p15 genes in acute leukemia with MLL gene rearrangements and their correlation with clinical features.
    Ohnishi H; Guo SX; Ida K; Taki T; Naritaka S; Bessho F; Yanagisawa M; Hanada R; Eguchi M; Kamada N; Kita K; Yamamori S; Hayashi Y
    Leukemia; 1997 Dec; 11(12):2120-4. PubMed ID: 9447829
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Variable expression of p16 protein in patients with acute myeloid leukemia without gross rearrangements at the DNA level.
    Jamal R; Thomas NS; Gale RE; Linch DC
    Leukemia; 1996 Apr; 10(4):629-36. PubMed ID: 8618439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genomic DNA and messenger RNA expression alterations of the CDKN2B and CDKN2 genes in esophageal squamous carcinoma cell lines.
    Zhou X; Suzuki H; Shimada Y; Imamura M; Yin J; Jiang HY; Tarmin L; Abraham JM; Meltzer SJ
    Genes Chromosomes Cancer; 1995 Aug; 13(4):285-90. PubMed ID: 7547637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.